IN2014DN04588A - - Google Patents

Info

Publication number
IN2014DN04588A
IN2014DN04588A IN4588DEN2014A IN2014DN04588A IN 2014DN04588 A IN2014DN04588 A IN 2014DN04588A IN 4588DEN2014 A IN4588DEN2014 A IN 4588DEN2014A IN 2014DN04588 A IN2014DN04588 A IN 2014DN04588A
Authority
IN
India
Prior art keywords
4alkyl
salt
compound
formula
Prior art date
Application number
Other languages
English (en)
Inventor
Philippe Robert Schils Didier
Elisabeth Stappers Alfred
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of IN2014DN04588A publication Critical patent/IN2014DN04588A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
IN4588DEN2014 2005-05-26 2006-05-24 IN2014DN04588A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05104531 2005-05-26
US68599305P 2005-05-31 2005-05-31
PCT/EP2006/062606 WO2006125809A1 (en) 2005-05-26 2006-05-24 Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile

Publications (1)

Publication Number Publication Date
IN2014DN04588A true IN2014DN04588A (ru) 2015-07-10

Family

ID=35822492

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4588DEN2014 IN2014DN04588A (ru) 2005-05-26 2006-05-24

Country Status (20)

Country Link
US (2) US8101752B2 (ru)
EP (1) EP1888537B1 (ru)
JP (2) JP5148483B2 (ru)
CN (1) CN101248051B (ru)
AU (1) AU2006251163C1 (ru)
BR (1) BRPI0611038B8 (ru)
CA (1) CA2609716C (ru)
DK (1) DK1888537T3 (ru)
ES (1) ES2437202T3 (ru)
HK (1) HK1123551A1 (ru)
HR (1) HRP20131133T1 (ru)
IN (1) IN2014DN04588A (ru)
ME (1) ME01612B (ru)
MX (1) MX2007014881A (ru)
PL (1) PL1888537T3 (ru)
PT (1) PT1888537E (ru)
RS (1) RS53062B (ru)
RU (1) RU2458056C2 (ru)
SI (1) SI1888537T1 (ru)
WO (1) WO2006125809A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006125809A1 (en) * 2005-05-26 2006-11-30 Tibotec Pharmaceuticals Ltd Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile
WO2012125993A1 (en) 2011-03-17 2012-09-20 Teva Pharmaceutical Industries Ltd. Solid state forms of rilpivirine base, and rilipivirine salts
US10112972B2 (en) 2012-03-13 2018-10-30 Octapharma Ag Process for production of fibrinogen and fibrinogen produced thereby
CN103058936B (zh) * 2013-01-23 2016-01-06 宁波九胜创新医药科技有限公司 4-[(4-氯-2-嘧啶基)氨基]苯腈的制备方法
CN103193719B (zh) * 2013-04-08 2015-07-22 宁波九胜创新医药科技有限公司 一种4-[(4-羟基-2-嘧啶基)氨基]苯腈的制备方法
CN114933567B (zh) * 2022-04-29 2023-07-11 武汉工程大学 一种2-甲硫基-4-嘧啶酮的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63502B1 (en) * 1989-04-21 1995-05-03 Zeneca Ltd Aminopyrimidine derivatives useful for treating cardiovascular disorders
RU2037483C1 (ru) * 1989-07-20 1995-06-19 Мерк Патент Гмбх Способ получения замещенных ароматических нитрилов
DE3923979A1 (de) 1989-07-20 1991-01-24 Merck Patent Gmbh Verfahren zur herstellung von aromatischen nitrilen
ATE232521T1 (de) * 1998-03-27 2003-02-15 Janssen Pharmaceutica Nv Hiv hemmende pyrimidin derivate
BRPI9915552B8 (pt) * 1998-11-10 2021-05-25 Janssen Pharmaceutica Nv pirimidinas inibidoras da reprodução do hiv
SK285240B6 (sk) * 1999-09-24 2006-09-07 Janssen Pharmaceutica N. V. Antivírusové prostriedky
DK1282607T3 (en) * 2000-05-08 2016-02-01 Janssen Pharmaceutica Nv Prodrugs of HIV replication inhibiting pyrimidines
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
CA2463822A1 (en) 2001-11-01 2003-05-08 Janssen Pharmaceutica N.V. Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
CN100554245C (zh) * 2002-08-09 2009-10-28 詹森药业有限公司 制备4-[[4-[[4-(2-氰基乙烯基)-2,6-二甲基苯基]氨基]-2-嘧啶基]氨基]苄腈的方法
EP1673348B1 (en) * 2003-09-30 2009-04-01 Janssen Pharmaceutica N.V. Benzoimidazole compounds
WO2006125809A1 (en) * 2005-05-26 2006-11-30 Tibotec Pharmaceuticals Ltd Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile

Also Published As

Publication number Publication date
RU2007148968A (ru) 2009-07-10
WO2006125809A1 (en) 2006-11-30
CN101248051B (zh) 2013-07-17
HRP20131133T1 (hr) 2014-01-03
JP2013040194A (ja) 2013-02-28
BRPI0611038A2 (pt) 2010-08-10
MX2007014881A (es) 2008-02-15
CA2609716C (en) 2014-10-14
AU2006251163B2 (en) 2012-03-08
AU2006251163A1 (en) 2006-11-30
US8618291B2 (en) 2013-12-31
BRPI0611038B8 (pt) 2022-10-25
CN101248051A (zh) 2008-08-20
CA2609716A1 (en) 2006-11-30
BRPI0611038B1 (pt) 2022-02-08
RU2458056C2 (ru) 2012-08-10
EP1888537B1 (en) 2013-09-11
RS53062B (en) 2014-04-30
US8101752B2 (en) 2012-01-24
PL1888537T3 (pl) 2014-02-28
ES2437202T3 (es) 2014-01-09
JP5148483B2 (ja) 2013-02-20
SI1888537T1 (sl) 2014-01-31
ME01612B (me) 2014-09-20
PT1888537E (pt) 2013-11-26
EP1888537A1 (en) 2008-02-20
HK1123551A1 (en) 2009-06-19
DK1888537T3 (da) 2013-12-09
US20080171878A1 (en) 2008-07-17
AU2006251163C1 (en) 2012-07-12
JP2008545680A (ja) 2008-12-18
JP5580385B2 (ja) 2014-08-27
US20120083606A1 (en) 2012-04-05

Similar Documents

Publication Publication Date Title
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
GB0521508D0 (en) Organic compounds
WO2007030582A3 (en) Acyclic ikur inhibitors
WO2005074642A3 (en) Chemical compounds
AU2006304874A8 (en) Pyrimidinones as casein kinase II (CK2) modulators
ME01992B (me) Jedinjenje diarilhidantoina
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
TW200634018A (en) Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and uses
MY158982A (en) Heterocyclic compound
CY1111671T1 (el) Ετεροκυκλικη ενωση
EA200801381A1 (ru) Производные пиримидина
WO2004035569A3 (de) Neue verbindungen mit antibakterieller aktivität
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
IN2014DN02014A (ru)
MX2009010824A (es) Compuesto de hidrazida heterociclica y uso pesticida del mismo.
TNSN08407A1 (en) Organic compounds
UA94833C2 (en) Substituted bicyclolactams
TNSN08191A1 (en) Kinase inhibitors
TW200732281A (en) Heterocyclic CETP inhibitors
SG171617A1 (en) Therapeutic compounds
GEP20105033B (en) Therapeutic agent for diabetes
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
HK1133258A1 (en) Methods of synthesizing pharmaceutical salts of a factor xa inhibitor
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
WO2007062314A3 (en) Heterocyclic cetp inhibitors